Enliven Therapeutics Inc (ELVN)
17.95
+0.16
(+0.90%)
USD |
NASDAQ |
Apr 30, 15:01
Enliven Therapeutics Price to Book Value: 3.018 for April 30, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 2.991 |
| April 26, 2024 | 2.889 |
| April 25, 2024 | 2.822 |
| April 24, 2024 | 2.941 |
| April 23, 2024 | 2.921 |
| April 22, 2024 | 2.963 |
| April 19, 2024 | 2.906 |
| April 18, 2024 | 2.971 |
| April 17, 2024 | 2.909 |
| April 16, 2024 | 3.143 |
| April 15, 2024 | 3.353 |
| April 12, 2024 | 3.544 |
| April 11, 2024 | 4.005 |
| April 10, 2024 | 3.333 |
| April 09, 2024 | 3.227 |
| April 08, 2024 | 3.077 |
| April 05, 2024 | 3.262 |
| April 04, 2024 | 3.128 |
| April 03, 2024 | 3.126 |
| April 02, 2024 | 3.161 |
| April 01, 2024 | 3.178 |
| March 28, 2024 | 2.958 |
| March 27, 2024 | 3.132 |
| March 26, 2024 | 2.961 |
| March 25, 2024 | 2.990 |
| Date | Value |
|---|---|
| March 22, 2024 | 3.107 |
| March 21, 2024 | 3.037 |
| March 20, 2024 | 3.23 |
| March 19, 2024 | 2.949 |
| March 18, 2024 | 2.125 |
| March 15, 2024 | 2.013 |
| March 14, 2024 | 1.940 |
| March 13, 2024 | 2.063 |
| March 12, 2024 | 2.144 |
| March 11, 2024 | 2.267 |
| March 08, 2024 | 2.500 |
| March 07, 2024 | 2.589 |
| March 06, 2024 | 2.598 |
| March 05, 2024 | 2.697 |
| March 04, 2024 | 2.803 |
| March 01, 2024 | 2.803 |
| February 29, 2024 | 2.682 |
| February 28, 2024 | 2.855 |
| February 27, 2024 | 2.969 |
| February 26, 2024 | 2.949 |
| February 23, 2024 | 2.776 |
| February 22, 2024 | 2.670 |
| February 21, 2024 | 2.714 |
| February 20, 2024 | 2.782 |
| February 16, 2024 | 2.819 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.595
Minimum
Dec 12 2023
4.005
Maximum
Apr 11 2024
2.514
Average
2.631
Median
Price to Book Value Benchmarks
| Eyenovia Inc | 4.263 |
| Phathom Pharmaceuticals Inc | -- |
| Lantern Pharma Inc | 1.344 |
| Vincerx Pharma Inc | 1.593 |
| NKGen Biotech Inc | -- |
Price to Book Value Related Metrics
| Price | 17.95 |
| Earnings Yield | -9.68% |
| Market Cap | 742.19M |